These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38304689)

  • 61. Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
    Bricker TL; Joshi A; Soudani N; Scheaffer SM; Patel N; Guebre-Xabier M; Smith G; Diamond MS; Boon ACM
    J Virol; 2024 Mar; 98(3):e0120623. PubMed ID: 38305154
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
    Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
    Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert.
    Temsah MH; Aljamaan F; Alenezi S; Alhasan K; Alrabiaah A; Assiri R; Bassrawi R; Alhaboob A; Alshahrani F; Alarabi M; Alaraj A; Alharbi NS; Halwani R; Jamal A; Al-Eyadhy A; AbdulMajeed N; Alfarra L; Almashdali W; Fayed A; Alzamil F; Barry M; Memish ZA; Al-Tawfiq JA; Alsubaie S
    Front Public Health; 2022; 10():878159. PubMed ID: 35400032
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models.
    Roth N; Gergen J; Kovacikova K; Mueller SO; Ulrich L; Schön J; Halwe NJ; Fricke C; Corleis B; Dorhoi A; Hoffmann D; Beer M; Maione D; Petsch B; Rauch S
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851196
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SARS-CoV-2 variants and vulnerability at the global level.
    Chavda VP; Patel AB; Vaghasiya DD
    J Med Virol; 2022 Jul; 94(7):2986-3005. PubMed ID: 35277864
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.
    Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S
    Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.
    Chadha J; Khullar L; Mittal N
    Environ Microbiol; 2022 Jun; 24(6):2615-2629. PubMed ID: 34320263
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 70. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.
    Noor R; Shareen S; Billah M
    Bull Natl Res Cent; 2022; 46(1):96. PubMed ID: 35431535
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Advances in the Omicron variant development.
    Vitiello A; Ferrara F; Auti AM; Di Domenico M; Boccellino M
    J Intern Med; 2022 Jul; 292(1):81-90. PubMed ID: 35289434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.
    González-Domínguez I; Martínez JL; Slamanig S; Lemus N; Liu Y; Lai TY; Carreño JM; Singh G; Singh G; Schotsaert M; Mena I; McCroskery S; Coughlan L; Krammer F; García-Sastre A; Palese P; Sun W
    Microbiol Spectr; 2022 Jun; 10(3):e0153822. PubMed ID: 35658571
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update.
    Mohapatra RK; El-Shall NA; Tiwari R; Nainu F; Kandi V; Sarangi AK; Mohammed TA; Desingu PA; Chakraborty C; Dhama K
    Hum Vaccin Immunother; 2022 Nov; 18(5):2065824. PubMed ID: 35594528
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort Study.
    Baerends EAM; Reekie J; Andreasen SR; Stærke NB; Raben D; Nielsen H; Petersen KT; Johansen IS; Lindvig SO; Madsen LW; Wiese L; Iversen MB; Benfield T; Iversen KK; Larsen FD; Andersen SD; Juhl AK; Dietz LL; Hvidt AK; Ostrowski SR; Krause TG; Østergaard L; Søgaard OS; Lundgren J; Tolstrup M
    Clin Infect Dis; 2023 Nov; 77(11):1511-1520. PubMed ID: 37392436
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas.
    Christensen PA; Olsen RJ; Long SW; Snehal R; Davis JJ; Ojeda Saavedra M; Reppond K; Shyer MN; Cambric J; Gadd R; Thakur RM; Batajoo A; Mangham R; Pena S; Trinh T; Kinskey JC; Williams G; Olson R; Gollihar J; Musser JM
    Am J Pathol; 2022 Apr; 192(4):642-652. PubMed ID: 35123975
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SARS-CoV-2 Omicron variant: A next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine.
    Mostafavi E; Dubey AK; Teodori L; Ramakrishna S; Kaushik A
    MedComm (2020); 2022 Mar; 3(1):e119. PubMed ID: 35281784
    [TBL] [Abstract][Full Text] [Related]  

  • 77. BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study.
    Yung CF; Pang D; Kam KQ; Lye DC; Ong B; Chong CY; Tan KB
    Lancet Child Adolesc Health; 2023 Jul; 7(7):463-470. PubMed ID: 37201540
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of Clinical Presentation and Vaccine Effectiveness Among Omicron and Non-omicron SARS Coronavirus-2 Patients.
    Mohanty M; Mishra B; Singh AK; Mohapatra PR; Gupta K; Patro BK; Sahu DP; Kar P; Purushotham P; Saha S; Das S; Mamidi P; Panda S; Mandal MC; Bhuniya S
    Cureus; 2022 Dec; 14(12):e32354. PubMed ID: 36628021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review.
    Shaheen N; Mohamed A; Attalla A; Diab RA; Swed S; Nashwan AJ; Rababah AA; Hefnawy MT; Soliman Y; Abdelwahab OA; Desouki MT; Khaity A; Shaheen A; Ramadan A; Meshref M
    Infect Drug Resist; 2022; 15():6317-6330. PubMed ID: 36345537
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential pathogenic and molecular features in neurological infection of SARS-CoV-2 Omicron BA.5.2 and BA.2.75 and Delta.
    Wang E; Yang QJ; Xu XX; Zou QC; Long Y; Ma G; Deng ZH; Zhao JB; Li MH; Zeng J
    J Med Virol; 2024 Jan; 96(1):e29357. PubMed ID: 38235532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.